To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)

Update Il y a 4 ans
Reference: NCT00537537

Woman and Man

  • | Country :
  • India
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This study is to evaluate the antiviral efficacy of add-on adefovir to telbivudine in non-responders to telbivudine monotherapy after 24 and 36 initial weeks. Antiviral efficacy is assessed by hepatitis B virus (HBV) DNA non-detectability (PCR <300 copies/ml) by week 104 with CHB.


Inclusion criteria

  • Hepatitis B, Chronic

Links